Cochrane · systematic review · CD008426
House dust mite reduction and avoidance measures for treating eczema
Nankervis, H, Pynn, EV, Boyle, RJ, et al. · Cochrane Database of Systematic Reviews · 2015 · Cochrane Library
SkinAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
4
current version
GRADE rated
3
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 1 · 25%Very low 3 · 75%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Comparison
Population: children and adults with eczema with proven sensitivity to house dust mite
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Clinician‐assessed global eczema severity using a named scale (Leicester Sign Score) | no estimate extracted | 1 study · 86 participants | Very low Downgraded: risk of bias |
Clinician‐assessed global eczema severity using a named scale (SASSAD) | no estimate extracted | 1 study · 60 participants | Very low Downgraded: imprecision |
Clinician‐assessed global eczema severity using a named scale (SCORAD) | no estimate extracted | 2 studies · 61 participants | Very low Downgraded: imprecision |
Participant‐ or caregiver‐assessed eczema‐related quality of life (named instrument) | no estimate extracted | 0 studies · 0 participants | Ungraded |